Crinetics Pharmaceuticals Inc (CRNX)
57.00
+0.31
(+0.55%)
USD |
NASDAQ |
Nov 04, 13:02
Crinetics Pharmaceuticals Max Drawdown (5Y): 68.70% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 68.70% |
| September 30, 2024 | 68.70% |
| August 31, 2024 | 68.70% |
| July 31, 2024 | 68.70% |
| June 30, 2024 | 68.70% |
| May 31, 2024 | 68.70% |
| April 30, 2024 | 68.70% |
| March 31, 2024 | 68.70% |
| February 29, 2024 | 68.70% |
| January 31, 2024 | 68.70% |
| December 31, 2023 | 68.70% |
| November 30, 2023 | 68.70% |
| October 31, 2023 | 68.70% |
| September 30, 2023 | 68.70% |
| August 31, 2023 | 68.70% |
| July 31, 2023 | 68.70% |
| June 30, 2023 | 68.70% |
| May 31, 2023 | 68.70% |
| April 30, 2023 | 68.70% |
| March 31, 2023 | 68.70% |
| February 28, 2023 | 68.70% |
| January 31, 2023 | 68.70% |
| December 31, 2022 | 68.70% |
| November 30, 2022 | 68.70% |
| October 31, 2022 | 68.70% |
| Date | Value |
|---|---|
| September 30, 2022 | 68.70% |
| August 31, 2022 | 68.70% |
| July 31, 2022 | 68.70% |
| June 30, 2022 | 68.70% |
| May 31, 2022 | 68.70% |
| April 30, 2022 | 68.70% |
| March 31, 2022 | 68.70% |
| February 28, 2022 | 68.70% |
| January 31, 2022 | 68.70% |
| December 31, 2021 | 68.70% |
| November 30, 2021 | 68.70% |
| October 31, 2021 | 68.70% |
| September 30, 2021 | 68.70% |
| August 31, 2021 | 68.70% |
| July 31, 2021 | 68.70% |
| June 30, 2021 | 68.70% |
| May 31, 2021 | 68.70% |
| April 30, 2021 | 68.70% |
| March 31, 2021 | 68.70% |
| February 28, 2021 | 68.70% |
| January 31, 2021 | 68.70% |
| December 31, 2020 | 68.70% |
| November 30, 2020 | 68.70% |
| October 31, 2020 | 68.70% |
| September 30, 2020 | 68.70% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
59.48%
Minimum
Nov 2019
68.70%
Maximum
Mar 2020
68.08%
Average
68.70%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| PTC Therapeutics Inc | 73.78% |
| Zevra Therapeutics Inc | 99.27% |
| Clearside Biomedical Inc | 94.66% |
| Biomea Fusion Inc | -- |
| NovaBay Pharmaceuticals Inc | 99.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 15.70 |
| Beta (5Y) | 0.6164 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 59.26% |
| Historical Sharpe Ratio (5Y) | 0.3991 |
| Historical Sortino (5Y) | 0.747 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.89% |